Season 2-Episode 51-HIV PrEP Therapy Explained

vs_twitter-card_1200x600Dr. Crystal Deas, PharmD, BCPS, an assistant professor of pharmacy practice at Samford University’s McWhorter School of Pharmacy, comes back to Healthy Dose® to discuss in more detail about the treatment regimens available today for HIV along with an in-depth analysis on how pre-exposure prophylaxis (PrEP) therapy can help patients who are at high risk for HIV.

Listen now below to Tuesday’s new Healthy Dose® episode which aired on 12-19-17 at 5pm on WVSU FM91.1 Birmingham! #healthydose #samfordpharmacy #WVSU #HIV #PrEP Crystal Deas 2.16

DID YOU KNOW?

Early detection is critical in being able to help a patient live a rather normal life with HIV. To find a HIV testing location near you, please visit the CDC website via the link below and insert your zip code or city in the box on the top right of the page.

CDC HIV Testing Site Near You

To find out more information about HIV, AIDS, treatment regimens, guidelines etc., please visit one of the websites below.

https://www.hiv.gov

https://aidsinfo.nih.gov

Season 2-Episode 50-HIV or AIDS, What’s the Difference?

hivDr. Crystal Deas, PharmD, BCPS, as assistant professor of pharmacy practice at Samford University’s McWhorter School of Pharmacy, discusses the differences between human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), who these diseases can affect most and what are ways to help prevent spreading or contracting the virus.

Listen now below to Tuesday’s new Healthy Dose® episode which aired on 12-12-17 at 5pm on WVSU FM91.1 Birmingham! #healthydose #samfordpharmacy #WVSU #HIV #AIDS #WorldAIDSDAY Crystal Deas 2.16

DID YOU KNOW?

If left untreated, HIV can lead to the most severe stage of HIV called AIDS.

HIV.gov

Season 2-Episode 49-Shingrix® vs. Zostavax®: A Shingles Vaccine Analysis Continued

Slide1

Dr. Michael Hogue, PharmD, FAPhA, FNAP, associate dean of the center of faith and hope and professor of pharmacy at Samford University’s McWhorter School of Pharmacy who is also a vaccine expert, returns to Healthy Dose® to talk more about the new Shingrix® vaccine and comparing it to the vaccine that we already have available Zostavax®.

Last week, on Healthy Dose® Episode 48, we discussed who should get the shingles vaccine and what the Centers for Disease Control and Prevention (CDC) recommends patients to do now that the new shingles vaccine is approved and recommended above Zostavax®.

On today’s episode, Dr. Hogue will discuss more about new the vaccine for shingles, Shingrix®, in terms of side effects, costs, and the effectiveness of the vaccine compared to Zostavax® based on the most current research available along with what other vaccines can be given at the same time and when the new vaccine could come to market.

Listen now below to Tuesday’s new Healthy Dose® episode which aired on 12-5-17 at 5pm on WVSU FM91.1 Birmingham! #healthydose #samfordpharmacy #WVSU #shingles #zostervaccines #shingrix #zostavaxhogue-michael

DID YOU KNOW?

The new shingles vaccine, Shingrix®, has a 95% effectiveness rate in preventing the shingles virus that will last for 20 years as opposed to Zostavax® which is about 50% effective and lasts about 6 years.

Shingrix package insert

Zostavax package insert

CDC Recommendations